))
Fast Five: Haemonetics buys Attune Medical, Medtronic faces jury trial in spine implant suit
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on October 11, 2024 03:40 (
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 404949872 series 3481361
Contenu fourni par Fast Five by MassDevice. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Fast Five by MassDevice ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 6, 2024. Check out the show notes at massdevice.com/podcast. Medtronic may face a jury trial in a legal case over spine implants. Fast Five hosts Chris Newmarker and Sean Whooley break down the nearly decade-long history of this lawsuit and discuss the decision handed down by a judge in this case. Baxter has decided to close a facility in Massachusetts. Listen to learn all about Baxter's reasoning behind this facility closure and how it ties into a major acquisition made by the company a few years ago. Dexcom announced a new direct-to-watch feature for G7 CGM. The Fast Five hosts look at what this new feature is and examine some other good news from Dexcom. Stereotaxis submitted its Magic ablation catheter for U.S. and European approval. Find out more about this technology and hear about the company's intriguing fourth-quarter results as well. Haemonetics agreed to acquire esophagus-protecting device maker Attune Medical. Newmarker and Whooley discuss the technology that Attune brings to the table and how Haemonetics feels it will fit in as part of the company.
…
continue reading
161 episodes
Partager
